©The Author(s) 2020.
World J Transplant. May 29, 2020; 10(5): 117-128
Published online May 29, 2020. doi: 10.5500/wjt.v10.i5.117
Published online May 29, 2020. doi: 10.5500/wjt.v10.i5.117
Table 2 Recipient demographics
| Characteristic | n = 99 | |
| Recipient | ||
| Age/yr | Median (range) | 59 (18-72) |
| Gender/male | n (%) | 61 (62) |
| MELD at transplant | Median (range) | 21 (6-38) |
| Etiology | ||
| EtOH | n (%) | 25 (26) |
| NASH | n (%) | 23 (23) |
| HCC | n (%) | 18 (18) |
| HCV | n (%) | 9 (9) |
| Other | n (%) | 24 (24) |
| Peak AST (Day 1-7)/(IU/L) | Median (range) | 631 (144-13645) |
| Peak ALT (Day 1-7)/(IU/L) | Median (range) | 506 (87-5002) |
| INR (Day 7) | Median (range) | 1.1 (0.9-2.5) |
| Bilirubin (Day 7)/(mg/dL) | Median (range) | 1.9 (0.5-16.8) |
- Citation: Núñez K, Hamed M, Fort D, Bruce D, Thevenot P, Cohen A. Links between donor macrosteatosis, interleukin-33 and complement after liver transplantation. World J Transplant 2020; 10(5): 117-128
- URL: https://www.wjgnet.com/2220-3230/full/v10/i5/117.htm
- DOI: https://dx.doi.org/10.5500/wjt.v10.i5.117